Type in product code or name:
|EB06964||Goat Anti-HEXIM1 Antibody||Pep-ELISA, WB||100µg specific antibody in 200µl||Human, Mouse||$315.00|
Ordering Information for
Order direct from Everest
$49.00: Overnight shipping (not applicable to SB-shifix) to United States of America
Sent via overnight courier arrives approximately next day to mainland USA. Please note that your order will be shipped by our US partner Abcore LLC.
Now shipping direct to US customers! 99% of products are held in stock for immediate shipment, see individual product pages for availability.
Please order through the US Dollar shopping cart (links on each product page) or we accept orders by email (email@example.com), fax (888-841-9041), phone (888-320-4628). Please include the following information with your order:
In stock orders received by 13.30 PST on Monday through Thursday are shipped the same day.
Orders are shipped by our US logistics partner Abcore LLC.
Peptide with sequence C-HRQQERAPLSKFGD, from the C Terminus of the protein sequence according to NP_006451.1.
Please note the peptide is available for sale.
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing.
This antibody has been successfully used in IP on Human:
Andrii Bugai, Alexandre J.C. Quaresma, Caroline C. Friedel, Tina Lenasi, Christopher R. Sibley, Petra Kukanja, Koh Fujinaga, Melanie Blasius, Thomas Hennig, Jernej Ule, Lars Dölken, Matjaz Barboric
P-TEFb activation by RBM7 shapes a pro-survival transcriptional response to genotoxic stress
This antibody has been successfully used in Western blot in Human:
Dalibor Blazek, Fernando Teque, Carl Mackewicz, Matija Peterlin and Jay A. Levy.
The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells.
J Gen Virol. 2016 Jan;97(1):220-4.